Merck commences two global Phase III trials of Evobrutinib

New Data from Esketamine Nasal Spray Phase 3 Studies Showed Rapid Reduction of Depressive Symptoms in Adult Patients with Major Depressive Disorder Who Have Active Suicidal Ideation with Intent

MicuRx Pharmaceuticals Touts Positive Top-Line Results from a US Phase 2 ABSSSI Clinical Trial of Novel Antibiotic Contezolid Acefosamil

Fractyl Touts Positive Topline Results in the Revita-2 Clinical Trial in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Bellus Health Raises USD 70m from Stock Offering

Alexion, BridgeBio Ink Japanese License Agreement for Eidos' Transthyretin Amyloidosis Investigational Medicine

New Preclinical Research Suggests Tetra Therapeutics' BPN14770 Protects Against Memory Loss and Neuronal Atrophy in Alzheimer's Disease

Personalis Enters Into Research Agreement with Invectys to Provide Comprehensive Tumor Immunogenomics Profiling for Clinical Trial

US FDA has Granted Priority Review of the Teprotumumab Biologics License Application for the Treatment of Active Thyroid Eye Disease

Ayala Pharmaceuticals names Gordon as Chief Medical Officer

Yuva Biosciences names new Advisory Board members

Imfinzi improves overall patient survival in AstraZeneca's phase III Caspian study

US FDA grants Orphan Drug designation to Acceleron Pharma's Sotatercept

Pfizer Touts Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants

Oncternal Appoints Kaufmann as Chief Scientific Officer, Bilinsky as Chief Business Officer